Omega Therapeutics, Inc.
OMGADelisted Mar 20, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001850838
Omega Therapeutics, Inc. was delisted on Mar 20, 2025; its insiders filed their last Form 4 on Dec 5, 2024; 53 institutions reported holding it in 13F filings for Q4 2024, worth $35.3M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Omega Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 68 | 1 | 54 | −13 |
| Shares | 50.6M | 364.0K | 48.3M | −1.88M (−3.7%) |
| Value | $104.7M | $753.4K | $59.0M | −$45.0M (−43.3%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Omega Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Siren, L.L.C. | 1,323,530 | $1.61M | 0.08% |
| BlackRock, Inc. | 271,651 | $331.4K | 0.00% |
| Green Alpha Advisors, LLC | 62,561 | $76.3K | 0.06% |
| Pathstone Holdings, LLC | 40,789 | $49.8K | 0.00% |
| Eqis Capital Management, Inc. | 12,538 | $15.3K | 0.00% |
| Principal Securities, Inc. | 1,370 | $1.67K | 0.00% |
| Simplex Trading, LLC | 1,509 | $1.00K | 0.00% |
Sold out (20)
Institutions that held Omega Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Artal Group S.A. | 1,323,530 | $2.74M |
| Jane Street Group, LLC | 213,497 | $441.9K |
| Goldman Sachs Group Inc | 190,107 | $393.5K |
| Y-Intercept (Hong Kong) Ltd | 77,417 | $160.3K |
| HRT Financial LP | 55,847 | $115.0K |
| Susquehanna International Group, LLP | 55,322 | $114.5K |
| Centiva Capital, LP | 43,800 | $90.7K |
| Paloma Partners Management Co | 27,700 | $57.3K |
| Ground Swell Capital, LLC | 19,170 | $39.7K |
| American Century Companies Inc | 18,048 | $37.4K |
| SEI Investments Co | 15,215 | $31.5K |
| Colony Group, LLC | 13,000 | $27.0K |
| Mirae Asset Global ETFs Holdings Ltd. | 13,016 | $26.9K |
| Schonfeld Strategic Advisors LLC | 11,700 | $24.2K |
| Rhumbline Advisers | 2,915 | $6.03K |
| Macquarie Group Ltd | 1,227 | $2.54K |
| Gradient Investments LLC | 900 | $1.86K |
| New York State Common Retirement Fund | 220 | $455 |
| Nisa Investment Advisors, LLC | 25 | $52 |
| CWM, LLC | 41 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Omega Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 363,953 | $753.4K |